Search details
1.
S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability in multiple myeloma.
Haematologica
; 109(1): 256-271, 2024 Jan 01.
Article
in English
| MEDLINE | ID: mdl-37470139
2.
Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis.
J Pathol
; 260(2): 112-123, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36807305
3.
Targeting the ß2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism.
J Pathol
; 259(1): 69-80, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36245401
4.
Transition in enuresis patients: Identifying the gaps and opportunities for the future.
Neurourol Urodyn
; 2024 Apr 08.
Article
in English
| MEDLINE | ID: mdl-38587243
5.
Mental health and professional outcomes in parents of children with chronic kidney disease.
Pediatr Nephrol
; 2024 Apr 23.
Article
in English
| MEDLINE | ID: mdl-38653885
6.
Illness-related parental stress and quality of life in children with kidney diseases.
Pediatr Nephrol
; 38(8): 2719-2731, 2023 08.
Article
in English
| MEDLINE | ID: mdl-36929385
7.
Validity and reliability of the Dutch version of the PedsQL™ 3.0 End Stage Renal Disease Module in children with chronic kidney disease in Belgium.
Pediatr Nephrol
; 37(5): 1087-1096, 2022 05.
Article
in English
| MEDLINE | ID: mdl-34599378
8.
Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions.
Int J Mol Sci
; 23(2)2022 Jan 14.
Article
in English
| MEDLINE | ID: mdl-35055096
9.
Kinome expression profiling to target new therapeutic avenues in multiple myeloma.
Haematologica
; 105(3): 784-795, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31289205
10.
The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma.
Br J Cancer
; 120(12): 1137-1146, 2019 06.
Article
in English
| MEDLINE | ID: mdl-31089208
11.
DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells.
Br J Cancer
; 118(8): 1062-1073, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29500406
12.
Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation.
J Pathol
; 241(4): 534-546, 2017 03.
Article
in English
| MEDLINE | ID: mdl-27976373
13.
Metabolic Features of Multiple Myeloma.
Int J Mol Sci
; 19(4)2018 Apr 14.
Article
in English
| MEDLINE | ID: mdl-29662010
14.
Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells.
Blood
; 124(4): 555-66, 2014 Jul 24.
Article
in English
| MEDLINE | ID: mdl-24928860
15.
Stimulation of invariant natural killer T cells by α-Galactosylceramide activates the JAK-STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model.
Br J Haematol
; 167(5): 651-63, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25142285
16.
Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibition.
Blood
; 119(3): 826-37, 2012 Jan 19.
Article
in English
| MEDLINE | ID: mdl-22128141
17.
The Biology of Stress Intolerance in Patients with Chronic Pain-State of the Art and Future Directions.
J Clin Med
; 12(6)2023 Mar 14.
Article
in English
| MEDLINE | ID: mdl-36983246
18.
Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma.
J Immunother Cancer
; 11(1)2023 01.
Article
in English
| MEDLINE | ID: mdl-36650020
19.
RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma.
Front Immunol
; 14: 1286700, 2023.
Article
in English
| MEDLINE | ID: mdl-38035078
20.
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia.
Blood Cancer J
; 13(1): 188, 2023 12 18.
Article
in English
| MEDLINE | ID: mdl-38110349